Hemostemix Inc. fell 16.7% on Monday, November 2, 2026, on 56,700 shares, 2.1 times its average daily volume. No headline about HEM came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
Hemostemix Inc. (HEM:TSXV) closed at $0.050 on November 6, 2026, down 9.09% on the day. The stock trades 54.5% below its 52-week high of $0.110 and 25.0% above its 52-week low of $0.040. Over the past year, it lost 44.4%. Hemostemix Inc. is part of the Life Sciences sector (Biotechnology).
In 252 trading sessions since November 6, 2025, HEM closed higher on 54 days (21%). Its best day was July 8, 2026 (+33.33%) and its worst was October 13, 2026 (-20.00%). The stock moved 10% or more in a single session 20 times. It opened at least 5% above the previous day's high 27 times.
Hemostemix Inc is a biotechnology company. The Company is engaged in developing, manufacturing and commercializing adult stem cell therapies to treat a variety of diseases.
Find more stocks like HEM with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.